Product Information
BUMETANIDE 0.5 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1265 per EA under NDC 68382052501. Its NADAC has been published 391 times since Sep 12, 2018.
FDA first approved this application on Apr 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the bumetanide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382052501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202900FDA Approved
4/30/2018
TE Code
AB
On Market Since
5/1/2018
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 0.5 MG TABLET has been published 391 times since Sep 12, 2018, and over the history we have for it it has declined 75.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1265 per EA |
|---|---|
| All-time high | $0.6244 (Sep 11, 2019) |
| All-time low | $0.1213 (May 22, 2024) |
| 52-week high | $0.1617 |
| 52-week low | $0.1265 |
| Median price | $0.2303 |
| Average price | $0.2872 |
| Largest weekly change | +29.3% (Jun 19, 2024) |
| Weeks tracked | 391 |
| Tracking since | Sep 12, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-21.7%
3Y
-46.1%
5Y
-58.4%
All
-75.4%
Last surveyed Mar 4, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUMETANIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 0.5 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1265 per EA (NDC 68382052501), effective Mar 4, 2026.
How has the price of BUMETANIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 0.5 MG TABLET has declined 75.4%. It has been tracked across 391 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 0.5 MG TABLET?
Since Sep 12, 2018, the NADAC for BUMETANIDE 0.5 MG TABLET has ranged from a low of $0.1213 (May 22, 2024) to a high of $0.6244 (Sep 11, 2019), with a median of $0.2303 per EA.
Are there cheaper alternatives to BUMETANIDE 0.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUMETANIDE 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUMETANIDE 0.5 MG TABLET?
BUMETANIDE 0.5 MG TABLET (NDC 68382052501) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.